Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
2A Pharma AB
AB
Active
Org 5590902788
Båtbyggaregatan 44, 216 42
Limhamn
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2016 · 9 years old
0 employees
Overvåg
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
2A Pharma AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
0M
2023
0M
2024
EBITDA
SEK millions
0M
-4M
-8M
-12M
-16M
-13M
2020
-10M
+23%
2021
-9M
+10%
2022
-1M
+89%
2023
-1M
0%
2024
Income statement
SEK thousands
Item
2020
2021
2022
2023
2024
Revenue
0
0
0
0
0
Staff expenses
—
—
—
—
—
EBITDA
−13 183
−10 181
−8 744
−772
−801
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
−13 183
−10 181
−8 744
−772
−801
Net financials
—
−867
−874
7
8
Profit before tax
−13 183
−11 049
−9 617
−765
−793
Tax
−0
−0
−0
−0
−0
Net profit
−13 183
−11 049
−9 617
−765
−793
Balance sheet
SEK thousands
Item
2020
2021
2022
2023
2024
Total assets
5 913
11 461
926
4 659
3 167
Equity
4 283
−6 765
717
3 952
3 160
Long-term debt
0
16 867
0
0
0
Short-term debt
1 630
1 359
209
707
7
Total debt
1 630
18 226
209
707
7
Financial ratios
5-year trend
EBITDA-margin
-80100000.0%
This company
15.8%
Market median
-506962125% vs market
2020
2024
Soliditetsgrad
99.8%
This company
38.2%
Market median
+161% vs market
2020
2024
Egenkapitalforrentning
-25.1%
This company
18.4%
Market median
-236% vs market
2020
2024
Nettoresultatgrad
-79300000.0%
This company
8.1%
Market median
-979012446% vs market
2020
2024
Aktivomsætning
0.00×
This company
1.12×
Market median
-100% vs market
2020
2024
Gæld/egenkapital
0.00×
This company
0.62×
Market median
+100% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on 2A Pharma AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
